BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
Source: marketscreener.com
📰 Gloria Bioscience News
Gloria Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gloria Bioscience. Real-time updates on events, politics, business and more.
Ligand's (LGND) Drug-Developing Technologies Holds Potential
Ligand's (LGND) Captisol technology is a key driver for its topline. The company plans to spin off another potential technology platform, OmniAb, into a separate company.
United States Gloria Bioscience Amgen Kyprolis Zacks Investment Research Ligand Pharmaceutical Zacks Investment
Source: entrepreneur.com